COMPARISON OF ADVERSE DRUG REACTIONS BETWEEN OLDER AND YOUNGER PATIENTS IN KOREA: USING ADVERSE EVENT REPORTING SYSTEM DATABASE FOR 2013-2015

被引:0
|
作者
Je, S. [1 ]
Kim, N. H. [1 ]
Song, S. M. [1 ]
Lim, S. J. [1 ]
Suh, D. [1 ]
机构
[1] Chung Ang Univ, Seoul, South Korea
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PHP126
引用
收藏
页码:A37 / A37
页数:1
相关论文
共 50 条
  • [41] Association between infection and severe drug adverse reactions: an analysis using data from the Japanese Adverse Drug Event Report database
    Takuya Imatoh
    Kimie Sai
    Chisato Fukazawa
    Yasushi Hinomura
    Ryosuke Nakamura
    Yoshimi Okamoto-Uchida
    Katsunori Segawa
    Yoshiro Saito
    European Journal of Clinical Pharmacology, 2017, 73 : 1643 - 1653
  • [42] Association between infection and severe drug adverse reactions: an analysis using data from the Japanese Adverse Drug Event Report database
    Imatoh, Takuya
    Sai, Kimie
    Fukazawa, Chisato
    Hinomura, Yasushi
    Nakamura, Ryosuke
    Okamoto-Uchida, Yoshimi
    Segawa, Katsunori
    Saito, Yoshiro
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (12) : 1643 - 1653
  • [43] Data mining and analysis for emicizumab adverse event signals based on the Food and Drug Administration Adverse Event Reporting System database
    Wei, Lianhui
    Tian, Ye
    Chen, Xiao
    Guo, Xiaojing
    Chen, Chenxin
    Zheng, Yi
    Xu, Jinfang
    Ye, Xiaofei
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (03) : 622 - 629
  • [44] Novel Adverse Event of Atezolizumab: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database
    Ahmed, Abdul Mannan Faruk
    Maheswari, Eswaran
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 306 - 306
  • [45] Data mining and analysis for emicizumab adverse event signals based on the Food and Drug Administration Adverse Event Reporting System database
    Lianhui Wei
    Ye Tian
    Xiao Chen
    Xiaojing Guo
    Chenxin Chen
    Yi Zheng
    Jinfang Xu
    Xiaofei Ye
    International Journal of Clinical Pharmacy, 2023, 45 : 622 - 629
  • [46] Comparison of Adverse Drug Reactions for Patients Treated with Tyrosine Kinase Inhibitors: Data Mining of the Public Version of the FDA Adverse Event Reporting System (AERS)
    Tanimoto, Tetsuya
    Oshima, Yasuo
    Yuji, Koichiro
    Kami, Masahiro
    BLOOD, 2011, 118 (21) : 739 - 740
  • [47] Comparison of brand versus generic antiepileptic drug adverse event reporting rates in the US Food and Drug Administration Adverse Event Reporting System (FAERS)
    Rahman, Md. Motiur
    Alatawi, Yasser
    Cheng, Ning
    Qian, Jingjing
    Plotkina, Annya V.
    Peissig, Peggy L.
    Berg, Richard L.
    Page, David
    Hansen, Richard A.
    EPILEPSY RESEARCH, 2017, 135 : 71 - 78
  • [48] Assessing taxane-associated adverse events using the FDA adverse event reporting system database
    Lao, Dong-Hui
    Chen, Ye
    Fan, Jun
    Zhang, Jian-Zhong
    CHINESE MEDICAL JOURNAL, 2021, 134 (12) : 1471 - 1476
  • [49] The Assessment of Characteristics of Adverse Events Following Immunization in Japanese Adverse Drug Event Report Database and Vaccine Adverse Event Reporting System for Signal Detection
    Miyazaki, Makoto
    Shito, Akihito
    Shimodera, Minoru
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 186 - 187
  • [50] Analysis of polypharmacy effects in older patients using Japanese Adverse Drug Event Report database
    Abe, Junko
    Umetsu, Ryogo
    Uranishi, Hiroaki
    Suzuki, Honami
    Nishibata, Yuri
    Kato, Yamato
    Ueda, Natsumi
    Sasaoka, Sayaka
    Hatahira, Haruna
    Motooka, Yumi
    Masuta, Mayuko
    Nakamura, Mitsuhiro
    PLOS ONE, 2017, 12 (12):